These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 10961174)
1. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings. Risberg B; Davidson B; Dong HP; Nesland JM; Berner A J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174 [TBL] [Abstract][Full Text] [Related]
2. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry. Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103 [TBL] [Abstract][Full Text] [Related]
3. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Pillai V; Cibas ES; Dorfman DM Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119 [TBL] [Abstract][Full Text] [Related]
4. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861 [TBL] [Abstract][Full Text] [Related]
5. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775 [TBL] [Abstract][Full Text] [Related]
6. Screening of carcinoma metastasis by flow cytometry: A study of 238 cases. Acosta M; Pereira J; Arroz M Cytometry B Clin Cytom; 2016 May; 90(3):289-94. PubMed ID: 26054018 [TBL] [Abstract][Full Text] [Related]
7. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls. Dong HP; Holth A; Berner A; Davidson B; Risberg B Cytometry B Clin Cytom; 2007 Sep; 72(5):332-43. PubMed ID: 17226863 [TBL] [Abstract][Full Text] [Related]
9. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Davidson B; Nielsen S; Christensen J; Asschenfeldt P; Berner A; Risberg B; Johansen P Am J Surg Pathol; 2001 Nov; 25(11):1405-12. PubMed ID: 11684957 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4. De Angelis M; Buley ID; Heryet A; Gray W Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens. Maguire B; Whitaker D; Carrello S; Spagnolo D Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591 [TBL] [Abstract][Full Text] [Related]
12. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
13. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA. Stoop JA; Hendriks JG; Berends D Cytopathology; 1992; 3(5):297-302. PubMed ID: 1288655 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids. Sayed DM; el-Attar MM; Hussein AA Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping. Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402 [TBL] [Abstract][Full Text] [Related]
16. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry. Queiroz C; Barral-Netto M; Bacchi CE Acta Cytol; 2001; 45(1):18-22. PubMed ID: 11213499 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids. Afify A; Zhou H; Howell L; Paulino AF Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901 [TBL] [Abstract][Full Text] [Related]
18. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions. He DN; Zhu HS; Zhang KH; Jin WJ; Zhu WM; Li N; Li JS World J Gastroenterol; 2004 Aug; 10(16):2406-8. PubMed ID: 15285029 [TBL] [Abstract][Full Text] [Related]
19. Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings. Arora R; Agarwal S; Mathur SR; Verma K; Iyer VK; Aron M Cytojournal; 2011; 8():14. PubMed ID: 21829416 [TBL] [Abstract][Full Text] [Related]
20. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4. Illingworth AL; Young JA; Johnson GD Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]